Bank of America Corp
Change company Symbol lookup
Select an option...
BAC Bank of America Corp
DGRW WisdomTree U.S. Quality Dividend Growth Fund
DFP Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP Flaherty & Crumrine Dynamic Preferred and Income Fund
DES WisdomTree U.S. SmallCap Dividend Fund
DEO Diageo PLC
DDF Delaware Investments Dividend and Income Fund
DAL Delta Air Lines Inc
D Dominion Energy Inc
CWB SPDR® Bloomberg Barclays Convertible Securities ETF

Financials : Banks | Large Cap Value
Company profile

Bank of America Corporation is a bank holding company and a financial holding company. The Company is a financial institution, serving individual consumers and others with a range of banking, investing, asset management and other financial and risk management products and services. The Company, through its banking and various non-bank subsidiaries, throughout the United States and in international markets, provides a range of banking and non-bank financial services and products through four business segments: Consumer Banking, which comprises Deposits and Consumer Lending; Global Wealth & Investment Management, which consists of two primary businesses: Merrill Lynch Global Wealth Management and U.S. Trust, Bank of America Private Wealth Management; Global Banking, which provides a range of lending-related products and services; Global Markets, which offers sales and trading services, and All Other, which consists of equity investments, residual expense allocations and other.


Last Trade
-0.30 (-1.27%)
B/A Size

Market Hours

Closing Price
Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low

10-day average volume:

Legionella Testing Market to Reach USD 455.99 Million by 2027; Increasing Popularity of PCR Tests Will Augment Growth, says Fortune Business Insights(TM)

9:39 am ET May 27, 2020 (Globe Newswire) Print

The global legionella testing market size is anticipated to gain traction from the increasing prevalence of legionnaire infection. In addition to this, the rapidly spreading pandemic of COVID19 that affects the respiratory system is also propelling the demand for legionella testing kits. A recently published report by Fortune Business Insights titled, "Legionella Testing Market Size, Share & Industry Analysis, By Type (Culture Media, Urine Antigen Testing (UAT), Polymerase Chain Reaction (PCR), Serology, and Direct Fluorescent Antibody (DFA) test; By End User (Hospitals & Clinics, Diagnostic Centers, and Others) and Regional Forecast, 2020-2027," provides details into the market and its prime growth trajectories. According to this report, the value of this market is poised to rise from USD 226.24 million in 2019 to USD 455.99 million by 2027, exhibiting a CAGR of 9.1% between 2020 and 2027.

Request a Sample Copy of the Research Report:

The Report Answers the following Questions?

-- How fierce is the competition of the market?

-- How will the imposition of stringent regulations on freshwater water testing boost the market?

-- Which strategies are executed by market players? How far is the success rate?

-- What is the impact of the COVID19 pandemic on the legionella testing market?

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

To get the short-term and long-term impact of COVID-19 on this Market.

Please visit:

Drivers & Restraints-

Increasing Regulations Imposed on Water Reserves by Governments will Augment Growth

Legionella is a disease caused by the bacteria called legionella pneumophilia found in water sources that may or may not be potable. They can grow in various water sources such as bathtubs, showers, ponds, swimming pools, and others. This acts as a major legionella testing market growth driver. Besides this, the launch of various techniques such as urine antigen testing, microbial culture method, and other commercially available tests are adding impetus to the market.

On the contrary, lack of awareness about this disease, coupled with the lack of proper healthcare infrastructure and diagnostic equipment especially in the underdeveloped regions may pose a major hindrance to the overall market.

Nevertheless, government support in terms of strict water system testing regulations and continuous monitoring of water reserves is likely to create lucrative growth opportunities for the market in the foreseeable future.


Cost efficiency and Rapid Test Results to Help UAT segment Emerge Dominant

Based on type, the market was dominated by the Urine Antigen Testing or the UAT segment in 2019 with a 42.2% share. This is due to its cost efficiency and the fact that's the results of these tests can be availed on the same day as compared to the traditional testing methods that require 7-8 days for producing test results.

Regional Analysis-

North America to Emerge Dominant with Presence of World-class Medical Infrastructure

North America earned the highest legionella testing market share on account of the presence of well-established healthcare infrastructure and medical facilities, coupled with high awareness about the disease and the strict regulations imposed by the government on water testing. On the other side, the increasing outbreak of legionella in the European nations, along with high pricing and the increasing popularity of the PCR test will help this region to come in close competition with North America.

Quick Buy - Legionella Testing Market Research Report:

Competitive Landscape-

Vendors Engage in Adoption of Latest Testing Technology for Better Revenue Generation

The nature of this market is consolidated on account of the presence of a few players. Key vendors are focusing on expanding their portfolio across geographies to gain a competitive edge in the market. Others are investing in research and development of new advanced testing methods and engaging in mergers and acquisitions, joint ventures, and other collaborative strategies to maintain a strong foothold in the market in the forthcoming years.

Some of the key Industry Developments of the Legionella Testing Market are listed below:

June 2018 - Legionella Water testing system was launched by Oxford Biosystems at the WMSoc Conference that gives precise results within 4 hours.

September 2019 - Hydrosense and B&V Chemicals entered into a strategic collaboration for the launch of a new-generation self-diagnostic tool for legionella.

Fortune Business Insights(TM) lists out the names of major players in this market. This includes:

-- Albagaia Ltd.

-- IDEXX Corporation

-- bioMérieux

-- BD

-- Thermo Fisher Scientific Inc.

-- Bio-Rad Laboratories, Inc.

-- Merck KGaA

-- Abbott (Alere)

-- Quidel Corporation

-- Other vendors

Have Any Query? Ask Our Experts:

Detailed Table of Content:

-- Introduction

    -- Research Scope

    -- Research Scope

    -- Market Segmentation

    -- Research Methodology

    -- Definitions and Assumptions

    -- Executive Summary

    -- Market Dynamics

      -- Market Drivers

      -- Market Drivers

      -- Market Restraints

      -- Market Opportunities

      -- Key Insights

        -- Prevalence of Legionella Infection by Key Countries

        -- Prevalence of Legionella Infection by Key Countries

        -- Key Industry Developments

        -- technological Advancements in Legionella Testing Kits

        -- Regulatory Scenario

        -- Market Analysis, Insights and Forecast, 2016-2027

          -- Key Findings / Summary

          -- Key Findings / Summary

          -- Market Analysis, Insights and Forecast - By Type

            -- Culture Media

            -- Culture Media

            -- Urine Antigen Testing (UAT)

            -- Polymerase Chain Reaction (PCR)

            -- Serology

            -- Direct Fluorescent Antibody Test (DFA)

            -- Market Analysis, Insights and Forecast - By End User

              -- Hospitals & Clinics

              -- Hospitals & Clinics

              -- Diagnostic Centers

              -- Others

              -- Market Analysis, Insights and Forecast - By Region

                -- North America

                -- North America

                -- Europe

                -- Asia Pacific

                -- Latin America

                -- Middle East & Africa

                TOC Continued....!!!

                Request for Customization:

                Have a Look at Related Reports:

                In-vitro Diagnostics (IVD) Market Size, Share & Industry Analysis, By Product Type (Instruments, Reagents & Consumables), By Technique (Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Point of Care, Hematology and Others), By Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology, Others), By End User (Clinical Laboratories, Hospitals, Physicians Offices, Others) and Regional Forecast, 2019 - 2026

                Point of Care (POC) Diagnostics Market Size, Share and Global Trend By Product (Blood Glucose Monitoring, Infectious Diseases, Cardiometabolic Diseases, Pregnancy and Fertility Testing Products, Hematology Testing Products, Others), By End User (Hospitals Bedside, Physician's Office Lab, Urgent Care & Retail Clinics, Home and Self Testing) and Geography Forecast till 2026

                Veterinary Diagnostics Market Size, Share & Industry Analysis, By Product Type (Instruments and Reagents & Consumables), By Technique (Hematology, Immunohistochemistry, Molecular Diagnostics, Diagnostic Imaging, Clinical Biochemistry, and Others), By Animal Type (Livestock and Companion), End-user (Veterinary Hospitals & Clinics, Veterinary Reference Laboratories, and Others) and Regional Forecast, 2019-2026

                Infectious Disease Molecular Diagnostics Market Size, Share and Global Trend By Technology (Mass Spectroscopy, Capillary Electrophoresis, Next Generation Sequencing, Chips & Microarrays, In-Situ Hybridization), By Disease Indication (Hepatitis, Human Immunodeficiency Virus (HIV) Infection, Human Papillomavirus (HPV) Infection), By End User (Hospitals & Clinics, Diagnostic Centres, Research Institutes) and Geography Forecast till 2026

                About Us:

                Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

                Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

                At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

                Contact Us:

                Fortune Business Insights(TM) Pvt. Ltd.

                308, Supreme Headquarters,

                Survey No. 36, Baner,

                Pune-Bangalore Highway,

                Pune - 411045, Maharashtra, India.


                US :+1 424 253 0390

                UK : +44 2071 939123

                APAC : +91 744 740 1245


                Fortune Business Insights(TM)

                LinkedIn | Twitter | Blogs

                Press Release:


Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.